Treatment of Lower Transsphincteric Perianal Fistula: Fistulotomy With Marsupialization vs Open Wound

Randomized Clinical Trial for the Treatment of Lower Transsphincteric Perianal Fistula Using Fistulotomy With Marsupialization vs Open Wound

This study will compare the results of marsupialization versus open wound after fistulotomy in low transsphincteric perianal fistulas.

Study Overview

Detailed Description

This is a multi-center triple blinded randomized clinical trial in which we'll compare two techniques for the treatment of simple low transsphincteric perianal fistulas. 40 patients will undergo a fistulotomy with marsupialization and 40 patients will undergo a fistulotomy with open wound. There will be an inclussion visit in which personal information will be recorded and the consent will be signed. Randomization will be done after inclusion, following a balanced blocks model. Information of the surgery technic won't be available for the investigator. The patients will have a journal in which they'll write their postoperative symptoms. Follow up will be done at weeks 2, 4 and 6 by the main investigator of each center. Data will be based in clinical examination, patient's diary and medical records. Statistical analysis of the primary outcome will be based in a superiority analysis using the Mantel-Cox test, or in case needed, a multivariate Cox regression analysis. The secondary outcomes will be analyzed by comparing times, percentages, mean or median with parametric or non parametric tests as it corresponds.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Sant Pere De Ribes, Barcelona, Spain, 08810
        • Consorci Sanitari Alt Penedes i Garraf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Low transsphinteric perianal fistula, defined as a single tract in the lower third of the anal sphincter, confirmed by ultrasound and intraoperative evaluation.
  • Ability to understand the study, to sign the consent and to complete the follow-up.

Exclusion Criteria:

  • Under 18 years of age.
  • Complex/recurrent fistula.
  • Patients in which by clinical criteria is decided not to perform a fistulotomy.
  • Anorectal malignancy.
  • Crohn's desease.
  • ASA IV or other contraindication for surgery.
  • Inmunosuppressed patients or in treatment with steroids or cytotoxic drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Fistulotomy with marsupialization
40 patients with a simple low transsphincteric anal fistula. A fistulotomy with marsupialization is performed.
A probe is placed in the fistula tract and it's laid open over that probe. The tract is curretted. Wound edges are sutured to the bottom of the fistula using interrupted sutures of vicryl 3-0 completing the marsupialization.
Active Comparator: Fistulotomy with open wound
40 patients with a simple low transsphincteric anal fistula. A fistulotomy leaving the wound open is performed.
A probe is placed in the fistula tract and it's laid open over that probe. The tract is curretted. The wound is left open.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound healing time
Time Frame: 6 weeks
Comparisson of the time it takes for the wound to not have areas without epithelium after the fistulotomy between the group with marsupialization and the open wound group.
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain
Time Frame: 6 weeks
Maximum pain experienced by the patient in the postoperative period measured by the visual scale of pain.
6 weeks
Return to daily activities
Time Frame: 6 weeks
Days it takes the patients to return their daily activities (e.g. job).
6 weeks
Operating time
Time Frame: 60 minutes
Time the surgery takes since the assessment of the fistula tract to the beginning of dressing of the postoperative wound. It's measured in minutes.
60 minutes
Hospitalization time
Time Frame: 2 days
Days the patient has to stay admitted in the hospital.
2 days
Anal incontinence
Time Frame: 6 weeks
Postoperative anal incontinence measured by the Browning and Parks incontinence scale: I: normal continence, II: Continent for solid and liquid stools but not for flatus, III: Continent for solid stools only, IV: Complete incontinence.
6 weeks
Frequency of dressing change
Time Frame: 6 weeks
Number of times per day a patient needs a dressing change
6 weeks
Who performs the dressing change
Time Frame: 6 weeks
Indicate who performs the dressing change: Patient, family member or medical professional.
6 weeks
Postoperative wound infection
Time Frame: 6 weeks
Presence of erythema, induration surrounding the wound or suppuration with or without an isolated pathogenic microorganism.
6 weeks
Recurrence of the fistula
Time Frame: 1 year
Reappearance of the fistula after complete healing of the surgical wound within the period of the study.
1 year
Bleeding of the postoperative wound
Time Frame: 6 weeks
Number of bleeding episodes that require more changing of the dressings or assistance of a medical professional.
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jessica Gonzales, MD, CSAPG

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2021

Primary Completion (Estimated)

February 1, 2023

Study Completion (Estimated)

July 1, 2023

Study Registration Dates

First Submitted

January 21, 2021

First Submitted That Met QC Criteria

January 21, 2021

First Posted (Actual)

January 25, 2021

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 18, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perianal Fistula

Clinical Trials on Fistulotomy with marsupialization

Subscribe